Login / Signup

Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: A Systematic Review.

Fernando Rabioglio GiugniMelina de Oliveira Valdo GiugniHenrique Trombini PinesiFabio Cetinic HabrumLígia Nasi LaranjeiraErica Regina Ribeiro SadyErica Aranha SuzumuraLuis Henrique Wolff GowdakJosé Eduardo Krieger
Published in: Arquivos brasileiros de cardiologia (2024)
The findings from our review suggest that ADSC therapy is generally safe for patients with ischemic heart disease. However, further investigation is warranted to confirm its efficacy, particularly with larger clinical trials and in specific conditions where improvements in microcirculation may have a notable impact on clinical outcomes.
Keyphrases
  • clinical trial
  • mesenchymal stem cells
  • bone marrow
  • cell therapy
  • phase ii
  • randomized controlled trial
  • stem cells
  • double blind